(Q42781539)

7 November 2017

Angiotensin II antagonism and plasma radioreceptor-kinetics of candesartan in man (English)

1 reference

7 November 2017

C Malerczyk

1

1 reference

7 November 2017

B Fuchs

2

1 reference

7 November 2017

G G Belz

3

1 reference

7 November 2017

S Roll

4

1 reference

7 November 2017

R Butzer

5

1 reference

7 November 2017

K Breithaupt-Grögler

6

1 reference

7 November 2017

V Herrmann

7

1 reference

7 November 2017

S G Magin

8

1 reference

7 November 2017

A Högemann

9

1 reference

7 November 2017

B Voith

10

1 reference

7 November 2017

E Mutschler

11

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Clinical Pharmacology

7 November 2017

1 reference

7 November 2017

45

1 reference

7 November 2017

6

1 reference

7 November 2017

567-573

1 reference

Some quantitative uses of drug antagonists

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Angiotensin II receptors and angiotensin II receptor antagonists.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Cough and inhibition of the renin-angiotensin system.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Angiotensin II antagonists DuP 753 and TCV 116.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

A method for estimating the potency of angiotensin-converting enzyme inhibitors in man.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Renin system blockade as a therapeutic strategy. Past, present, and future.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Hemodynamic responses to angiotensin I in normal volunteers and the antagonism by the angiotensin-converting enzyme inhibitor cilazapril.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873652

Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man

16 August 2018

1 reference

12 December 2020

Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers

1 reference

12 December 2020

Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy

1 reference

12 December 2020

Widespread tissue distribution of human chymase

1 reference

12 December 2020

Development and validation of column-switching high-performance liquid chromatographic methods for the determination of a potent AII receptor antagonist, TCV-116, and its metabolites in human serum and urine

1 reference

12 December 2020

Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man

1 reference

12 December 2020

Theories of drug antagonism

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00722.X

Identifiers

DOI

1 reference

7 November 2017

1 reference

7 November 2017

1 reference